A new session has been added to Ceva Animal Health UK's Cardio Academy CPD website entitled "Thoracic X-rays: Abnormal Features". 

In the 30 minute multimedia presentation, the cardiology specialist Nicole Van Israël discusses X-ray abnormalities within the cardiovascular and respiratory systems of cardiac patients. This includes a discussion on how to measure heart size and how to identify and interpret lung patterns.

Participants can then receive a CPD certificate by completing the quiz for this session. The Cardio Academy CPD website is free of charge and can be accessed on www.cardioacademy.cevalearn.com.

In addition, the first four sessions can still be accessed which cover the Pathophysiology of Mitral Valve Disease by Adrian Boswood, Clinical Examination of the Cardiac Dog by Gérard Le Bobinnec and Thoracic X-rays - How to Proceed and Thoracic X-rays - Normal Features by Nicole Van Israël.

For further information, please contact your local Ceva account manager.

VetSurgeon member Neil Forbes FRCVS, Specialist in Avian Medicine at Vets Now Referrals, has been dealing with a rather interesting case: an owl that swallowed a sock. 

John Dowling, the owner of a falconry business and keeper of the 13 week old Indian eagle owl called Lydon noticed he was not eating properly, and then looked dazed and confused when taking part in the Stonehouse Horticultural Show & Summer Jolly. After the show, Lydon looked like he was trying to vomit but couldn't, so John took him to Vets Now Referrals in Swindon for a consultation.

Neil examined Lydon and found there was a hard swelling in his abdomen. Radiographs confirmed a bloated and very full stomach. The decision was taken to operate on Lydon to remove whatever was inside. Fearing a growth or tumour, Neil was rather surprised to find instead a smelly old sock in Lydon's stomach. With the sock successfully removed, Lydon was able to go home a few hours later, none the worse for his experience.

Lydon's owner, John, said: "Lydon is a hand-reared Indian eagle and is often in and around the house. The sock is a toy he has played with since he was a owlet, and never did I think he would, or could, have eaten it!

"I was obviously surprised when Neil found the sock in Lydon's stomach but more relieved than anything. I feared the worst but was delighted to find out it wasn't something more sinister."

Neil said: "Never in my 28 years of avian medicine experience have I treated an owl that swallowed a sock, it's just unheard of. Thankfully John brought Lydon into our clinic for a consultation upon suspicion something wasn't quite right and we were able to remove the sock preventing further health deterioration.

"We would always advise owners of pets to be careful when leaving items around the house, as you can never predict how mischievous pets can be."

A research project funded by The Horse Trust has made important discoveries about how two peptides regulate the inflammatory response in horses. This knowledge could help with the development of improved anti-inflammatory drugs, which are used to treat a wide range of conditions in horses.

The research project was led by Professor Fiona Cunningham at the Royal Veterinary College in Hertfordshire and Dr Karen Rickards at the Donkey Sanctuary in Sidmouth, assisted by Dr Andrew Brooks at the RVC, and by Dr Kirstie Pickles, now at the Royal (Dick) School of Veterinary Studies in Edinburgh.

Inflammation is associated with a wide range of equine diseases, including recurrent airway obstruction, laminitis and sweet itch. Anti-inflammatory drugs, such as glucocorticosteroids, mainly work by blocking the formation and/or actions of compounds produced in the horse's body that cause inflammatory responses. However, these drugs are not always effective and can have unwanted side effects.

This research, funded by The Horse Trust, aimed to find out more about two naturally-occurring peptides - chains of amino acids that are shorter than proteins - known as annexin-1 and CXCL8. Both have been shown to affect the inflammatory response but little research has been done on their effects in horses. In the long term, knowing more about these compounds could help in the development of new anti-inflammatory drugs with fewer side effects.

During inflammation, neutrophils (a type of white blood cell) stick to the cells lining blood vessels and migrate into inflamed tissue, where they ingest and break down harmful agents. Using techniques that mimic these events, CXCL8 was found to cause adherence and migration of horse neutrophils. However, when it was used in combination with another pro-inflammatory substance, neutrophil migration and adherence were markedly decreased.  This suggests that attempts to reduce inflammation by blocking the actions of CXCL8 might not be as beneficial as had been thought.

At the start of the project, the researchers had no information about horse annexin-1, other than its gene sequence, so their first step was to develop a method to detect the peptide in white blood cells. They established that it was present and, as horse annexin-1 has not yet been synthesised, they used a synthetic peptide derived from annexin-1, Ac2-26, to look at the effects on horse neutrophils.

They found that Ac2-26 decreased neutrophil adherence and migration in response to other pro-inflammatory compounds, although at high concentrations the peptide itself caused some cell activation, thereby increasing inflammation. They also found that dexamethasone (a glucocorticosteroid) increased the levels of annexin-1 in cells, indicating that, as in humans, this class of drugs is likely to act in part through the formation of annexin-1.

These findings suggest that the use of compounds which mimic the actions of annexin-1 may have limitations as anti-inflammatory drugs. As glucocorticosteroids partly work by forming annexin-1, further research is needed in order to find out how annexin-1 will act in the horse's body and establish how its formation contributes to the beneficial effects of these drugs.

Professor Cunningham said: "This Horse Trust-funded research has resulted in some very interesting findings about how inflammatory cells are regulated in horses. The receptors that annexin-1 and CXCL8 act upon could be targets for new equine inflammatory drugs, but more research is needed first to fully understand their actions and how they produce these effects."

The team's research has been accepted for publication by the journal Veterinary Immunology & Immunopathology.

The Animal Health Trust has cut the first sod of a new cancer centre for animals in Suffolk.

The AHT's Cancer Centre will provide all three treatment options: surgery, chemotherapy and radiotherapy, on one site. The cancer facility is being purpose-built to treat horses, dogs and cats.

Sue Murphy, Head of Clinical Cancer Treatment at the AHT, said: "Having all three treatment options on one site means that whatever the diagnosis, we will be able to offer each and every patient the very best options for their specific case. With one in four dogs and one in six cats developing cancer at some time in their life this new centre will help many more animals - from Suffolk, East Anglia and all across the UK."

The new centre will also further research into cancer. Treating animals with all types of the disease will enable the AHT's vets and scientists to expand current knowledge about cancer. This will help with the development of new ways to diagnose and treat the disease.

Vets and scientists at the AHT already work collaboratively with cancer researchers looking at the disease in humans. There are a number of links between human and animal cancers which have already been identified. It is hoped that knowledge gained from the AHT Cancer Centre may also help in the understanding of cancer in people.

The AHT hopes the building will open in summer 2012 . It is launching an appeal to raise much needed funds to equip the centre with a linear accelerator. This piece of specialist equipment works by delivering high-energy radiation beams to break cancerous tumours down while sparing the surrounding normal tissue.

The AHT Cancer Centre will be one of only six veterinary facilities in the UK to house a linear accelerator.

Sue Murphy added: "Currently, there is no way to tell which animals will, and which animals won't, develop cancer. It could happen to any animal at any time. This new centre will give more animals a fighting chance of beating the disease, enabling them to lead long and healthy lives. The fact that treatments developed to benefit our pets may also lead to improvements in the prevention and treatment of cancer in humans makes this centre all the more important.

"I would urge you to donate whatever you can to help equip the centre. Your donation, however large or small, will help many more animals beat cancer and it may also help in the fight against cancer in people."

If you would like to make a donation to the AHT Cancer Centre please visit www.aht.org.uk or telephone 01638 555648.

Alternatively you can make a £5 donation by textingVETS24 £5 to 70070

The RCVS Disciplinary Committee has suspended a Cardigan veterinary surgeon from the RCVS Register for five months, for failure to perform accurate bovine tuberculin testing and for falsely certifying the test results.

During the two-day hearing, Dewi Wyn Lewis, of Priory Veterinary Ltd, Cardigan, answered charges about inaccurate skin fold measurements and false certification relating to two visits he made as an Official Veterinarian to a farm in April 2009 to undertake tuberculin testing.

Mr Lewis accepted that he had not carried out the tuberculin tests in the way required by Animal Health (AH) - an Executive Agency of the Department for Environment, Food and Rural Affairs - and had taken short cuts to save time. However, he denied the charges, arguing that, although instructions to Official Veterinarians clearly required the use of callipers to measure the skin folds of cattle necks on Day One of testing, not using callipers and using his finger and thumb did not amount to failing to measure. 

He also argued (and it was accepted by the Committee) that, regarding Day Two of testing, there was inconsistency in AH's instructions on calliper use, which in written form required using callipers for measuring every animal but in practice accepted use of callipers when a reaction could be detected by manually palpating the skin. On Day Two, Mr Lewis said, he had done what AH required: he had used callipers on the cattle he identified for closer examination.

The Committee, however, found that by failing to use callipers on the first day, as required by AH, Mr Lewis had failed to measure the skin folds of almost all of the 104 cattle. The Committee was also satisfied that, on the second day, 10-20% of the herd were not even touched by Mr Lewis and the Committee accepted the evidence of the three other witnesses present during the testing, which indicated that Mr Lewis had failed to carry out careful assessment and manual palpation of every animal.

The Committee then considered whether Mr Lewis had dishonestly signed the certificate, or had signed a false certificate which he ought to have known was inaccurate. The Committee noted that there were no previous Disciplinary findings against Mr Lewis, and was prepared to believe his assertion that, although he knew he had not carried out the tests in strict compliance with AH's instructions, he genuinely believed his methods to be at least as accurate as measuring with callipers and did not think he was doing anything wrong or dishonest. The Committee could not then be sure that Mr Lewis had realised what he was doing was dishonest. However, the Committee noted that 'false' also means 'inaccurate' and, as Mr Lewis ought to have known that as his testing methods were not adequate, he also should have known that a considerable number of measurements on the certificate were inaccurate and that the certificate itself was inaccurate. 

After considering the facts of the case, the Committee concluded that Mr Lewis's actions amounted to serious professional misconduct and directed that he should be suspended from the Register for five months, after which he may return to practice. In relation to the sanction, the Committee said:  "In reaching this decision it is relevant that the false certification was not dishonest and that there was professional and personal mitigation put forward on behalf of Mr Lewis. The Committee has paid regard to the fact that Mr Lewis is an experienced veterinary surgeon who is highly thought of in his local area. It does not believe that there is any likelihood that he will repeat his previous conduct."

The Committee also said it gave considerable weight to the fact that Mr Lewis had had to wait an additional three-month period for the hearing because of an earlier adjournment.

Novartis Animal Health has launched a 0.5L pack of the anthelmintic Zolvix to make the product more readily available for quarantine dosing, and for the smaller sheep farmer.

Novartis says that because Zolvix is a broad spectrum anthelmintic that has the ability to kill all common sheep gastro-intestinal nematodes, including those resistant to existing treatments, it has a key role to play in quarantine treatment to keep parasite infection down to a minimum.

Simon Harris, Endoparasite Brand Manager at Novartis Animal Health, said: "As the first of the new generation of the Orange or 4-AD anthelmintic group, Zolvix has demonstrated effectiveness in killing worms, even those resistant to other products.

"Sheep farmers are being encouraged to use Zolvix as a quarantine treatment that can significantly reduce worm burdens on farm. I would stress that it is essential guidelines are followed in order to preserve Zolvix's ability to combat nematodes that have acquired resistance to other classes of wormers.

"This new pack size is aimed at farmers who are introducing new stock to their flocks, but will also be convenient for the smaller sheep farmer and smallholders who don't require such a large quantity of product."

Novartis says that because Zolvix is a short-acting anthelmintic, it does not encourage resistance to develop through a long duration of action. It has a high margin of safety so can be used to treat sheep and lambs including pregnant or lactating ewes and breeding rams. Its short meat withhold period of just seven days allows flexibility when marketing lambs.

Ceva Animal Health UK has launched a new Galastop iPhone application to calculate the optimal date for spaying in order to reduce the risk of post-operative false pregnancy.

Enter the end of oestrus date (when the last season finished), and the app will calculate when to spay, i.e. 16 weeks later.

Ceva says it is important not to spay a bitch during a false pregnancy as post-operative chronic pseudopregnancy may develop, which can last longer and be more resistant to standard treatment. However, some cases of false pregnancy can be silent and difficult to detect. Product manager at Ceva Animal Health UK, Fraser Broadfoot MRCVS, said: "It is commonly recommended to wait until 12 weeks after the end of oestrus before spaying. However, silent pseudopregnancy can still occur at this stage so, to be on the safe side, many specialists are now recommending spaying later at 16 weeks after the end of oestrus."

Click here for more details, and to download the app in iTunes.

For further information, please contact your Ceva Animal Health UK representative or call the veterinary support team on 01494 781510.

The Royal College of Veterinary Surgeons is seeking feedback on a new draft Code of Professional Conduct for Veterinary Nurses.

The new draft Code, which would replace the existing RCVS Guide to Professional Conduct for Veterinary Nurses, has been produced by a Working Party set up by the RCVS Advisory Committee to review the Guides for both veterinary surgeons and veterinary nurses.

It is the benchmark for professional conduct against which registered veterinary nurses will be measured in any hearings on serious professional misconduct held by the recently-introduced VN Disciplinary Committee.

The purpose of the review is to ensure that guidance to the profession, and the public, is clear, for example, using consistent language to distinguish between what must be done and what is advised.

The new Code is a short, principles-based document, using the Federation of Veterinarians of Europe's Code of Conduct as the starting point. It will be supported by additional advice on specific areas of veterinary practice or issues, for example, clinical governance.

The consultation follows an earlier one for a new draft Code for veterinary surgeons that closed at the end of June: the new Code for veterinary nurses follows the format and style of that for veterinary surgeons. Comments made during the veterinary surgeon consultation will be taken account of alongside comments made during this new consultation.

For the first time, the draft proposes that veterinary nurses make a declaration on joining the VN Register, which underlines the primary importance of animal health and welfare: "I PROMISE AND SOLEMNLY DECLARE that my constant endeavour will be to ensure the welfare of animals committed to my care and that I will pursue the work of my profession with integrity and accept my responsibilities to my clients, the public, the profession and the Royal College of Veterinary Surgeons."

Comments on the proposed draft are invited from the veterinary nursing profession, the veterinary profession and the public, particularly on the issue of whether the Codes for veterinary nurses and veterinary surgeons ought to be combined.

Andrea Jeffery, the RCVS Veterinary Nurses Council member who led the group tasked with developing the new Code, said: "It is 50 years since the start of the veterinary nursing profession and the changes proposed in the Code reflect the development of our professional role over this time.

"This new Code is a simplified document that focuses on key principles and which will be supported by more detailed guidance. Although it follows the format of the draft Code for veterinary surgeons, it is important that we recognise our unique position as veterinary nurses."

The new Code, together with the consultation paper, can be downloaded at www.rcvs.org.uk/VNcodeconsultation.

Comments should be sent by email to Christopher Murdoch, Secretary to the Guides Review Working Party, at c.murdoch@rcvs.org.uk by Friday, 21 October 2011.

Virbac Animal Health has produced a Pet Oral Hygiene System point of sale kit for practice reception areas.

The pack includes information for owners on periodontal disease and gingivitis and advice on preventative routine care. It also provides guidance for owners who struggle to brush their pet's teeth correctly, including where to find Virbac CET 'You Tube' footage.

Virbac Oral Care product manager Chris Geddes MRCVS says still more is needed when it comes to oral home care: "Some experts state that four out of every five dogs over the age of three suffers from periodontal disease - despite this many pet owners have no form of oral care programme.

"The idea behind this kit is to highlight to owners the importance of oral hygiene at the time when they are in the most appropriate place to get expert advice!"

Packs are free to any practice spending £50.00 or more on the Virbac oral care range including VeggieDent chews and Vet aquadent drinking solution.

For more information contact your local Virbac territory manager or call Virbac on 01359 243243.

Alstoe Animal Health has launched Easeflex for Cats, a mobility support supplement containing Glucosamine, Chondroitin, MSM and anti-oxidants in a palatable triangular-shaped chew.

Alstoe says stiffness in cats may be linked to changes within the synovial joints and can often go unrecognised. To help owners identify the problem, Alstoe has invented "Chedda" the Easeflex cartoon cat. The client information pack that Alstoe offers to practices consists of leaflets with graphics which outline to the owner how stiffness affects Chedda's lifestyle. .

Sales of joint supplements for cats have lagged well behind those for dogs. Alstoe says this can be explained by the difficulty in administration to chronically affected cats, but that Easeflex's unique texture, shape and flavoured base of fish and cheese, should lead to a marked improvement in compliance rates amongst pets and owners.

Easeflex for Cats is now available at wholesalers and the client information material featuring "The adventures of Chedda" is available from Alstoe by calling 01347 878606 or contacting info@alstoe.co.uk.

Norbrook Laboratories Ltd has relaunched its website with a focus on veterinary technical support, farmers and pet owners, and a new online recruitment system.

The new site has sections dedicated specifically to farm animal, equine and pet healthcare. Norbrook says each section will feature articles and information on relevant issues in addition to help and support for the company's animal health pharmaceutical product ranges.

Alanna Carty, European Marketing Director said: "Animal Healthcare is a massive area within which there are a range of very different users and requirements. On our new website, we have categorised three specific groups - Farm Animals, Horses and small companion animals or pets.  Users can now easily navigate directly to the specific area they are interested in and obtain the information they need in an instant. In addition, we have included articles and information on relevant topics eg Bovine Respiratory Disease or Arthritis in cats and dogs which will help animal health carers to keep abreast of key issues in what is a fast-changing environment"

The new site also incorporates a Veterinary Technical Support section dedicated to veterinary surgeons, veterinary nurses and practice managers.  Alanna said: "Time is a precious commodity for veterinary surgeons and nurses. They need information on drugs and treatments as quickly as possible and our new website has been designed to meet this need.  Our quick search allows vets and assistants to quickly identify products they may wish to use and our full Product Compendium is also available online."

The site also includes a new online recruitment section which aims to streamline the process for the 3000 or so applications the company currently receives each year.

Mrs Louise Kirk, Head of Personnel said: "The beauty of the online recruitment system is that it makes life easier for everyone involved in the process.  Applicants have more time to complete the application form because they can begin online as soon as they become aware of the advertised position.  They can begin to complete the form, save it and return to it or amend it until they are happy to submit it, at which point they receive a confirmation email and a pdf copy of their application form.  However the system also allows for the form to be downloaded and posted to applicants who are unable to use the online system."

www.norbrook.com

Scientists at the Royal Veterinary College, contributing to a programme to tackle some of the most harmful and widespread endemic diseases that commonly affect farmed animals in the UK, have developed a severity estimation calculator for post-weaning multi-systemic wasting syndrome (PMWS).

Post-weaning multi-systemic wasting syndrome (PMWS) is a common disease of young pigs in the U.K. It is extremely debilitating, causes considerable suffering and poor welfare, and has a high mortality of up to 30%. It is estimated that the disease costs the UK farming industry £30m per year.

The £2.4m project - headed by Professor Dirk Werling from the Royal Veterinary College and funded by the Biotechnology and Biological Sciences Research Council (BBSRC) through its "Combating Endemic Diseases For Farm-Animal Sustainability" programme (CEDFAS), the British Pig Executive (BPEX), and two industrial partners, Pfizer Ltd (UK) and BioBest - aims to identify why PMWS occurs and to develop new methods of controlling the disease.

One key-component of the project is the direct involvement of British pig farmers, thereby guaranteeing that pigs in Britain will be the first to benefit from this research, while collaboration with a major international pharmaceutical company will ensure that new veterinary products will be made available to pig farmers worldwide.

Now, two members of the team, Dr. Barbara Wieland and Pablo Alarcon-Lopez, a second year PhD student, have developed a novel approach to quantify severity of PMWS based on morbidity and mortality data and presence of porcine circovirus type 2 (PCV2). They applied factorial analyses, using data collected from 147 pig farms in England to identify variables contributing to variation in PMWS severity in a biologically meaningful way.

Together with other known variables linked to PMWS, the resulting factors were used to derive an algorithm for PMWS severity. The derived algorithm was used to develop a PMWS severity calculator, which now can be used by farmers directly to assess the PMWS severity on their own farm (http://www.bpex.org.uk/articles/300874).

The levels of PMWS severities identified on farm level can now be used to identify risk factors related to the different severity-categories, to assess the efficacy of PCV2 vaccination and to investigate the economic impact of potential control measures on a farm.